Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (387)
- Scheduling (national classification system) (168)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
768 result(s) found, displaying 276 to 300
-
Scheduling decisions (final)Public notice - Delegate-only decisions to amend the Poisons Standard and New Chemical Entities (NCEs)
-
Scheduling decisions (final)Final decision on proposed amendment to the Poisons Standard relating to sodium nitrite (Joint ACMS-ACCS #28, June 2021)
-
Meeting statementsAdvisory Committee on Vaccines, meeting 28, 22 December 2021
-
Meeting statementsAdvisory Committee on Medicines, meeting statement now available
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 27, 1 December 2021
-
TGA laboratory testing reportsIn consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
Corporate reportsThe 2020-21 TGA Regulator Performance Framework Self-assessment (KPI) Report has now been published
-
-
Meeting statementsA meeting of the TGACC was held 6 December 2021. The Communique has now been published.
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard.
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 Joint ACMS-ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 Joint ACMS-ACCS meeting
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard relating to MDMA and psilocybin.
-
Corporate reportsPublication of the independent expert review of MDMA and psilocybin.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 1 November 2021.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed 1 November 2021.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 11 November 2021.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 11 November 2021
-
Meeting statementsAdvisory Committee on Vaccines. Meeting statement available.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement available.
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in March 2021
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in March 2021